Zephyrnet Logo

Merck will allow drugmakers in other countries to make its COVID-19 pill

Date:

United Nations-backed Medicines Patent Pool reached an agreement with Merck and its partner Ridgeback Biotherapeutics allowing MPP to license the manufacture of molnupiravir to pharmaceutical companies across the globe.

The drug, known as molnupiravir, has shown promise in treating the disease. The agreement to license its production could help millions of people in the developing world gain access to it.

(Image credit: Christopher Occhicone/Bloomberg via Getty Images)


PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://www.npr.org/sections/coronavirus-live-updates/2021/10/27/1049587575/merck-covid-pill-countries

spot_img

Latest Intelligence

spot_img